Ampullary Carcinoma
Brooke R. Jeffrey, MD
Amir A. Borhani, MD
Key Facts
Terminology
-
Malignant epithelial neoplasm (adenocarcinoma) arising from ampulla of Vater
Imaging
-
Ampullary mass with variable attenuation (most often hypodense) distinct from pancreas with dilated CBD and PD; nodal or liver mets in advanced cases
-
“Double duct” sign with obstruction of common bile duct and pancreatic duct
Top Differential Diagnoses
-
Pancreatic head carcinoma invading ampulla
-
Adenoma of ampulla
-
Distal cholangiocarcinoma
-
Mesenchymal tumor of ampulla
-
Duodenal carcinoma (adenocarcinoma)
Pathology
-
Lobulated soft tissue mass arising from ampulla of Vater
-
Markedly increased incidence in hereditary polyposis syndromes (e.g., familial adenomatosis coli, hereditary nonpolyposis colon cancer, etc.)
Clinical Issues
-
Jaundice (80%), weight loss (61%), abdominal pain, & back pain (46%) are most common symptoms
-
Better prognosis than periampullary carcinoma of biliary or pancreatic origin
Diagnostic Checklist
-
Duodenal distension with water on CECT key to identifying lesion
-
Perform dedicated pancreatic protocol when ampullary lesion suspected
TERMINOLOGY
Definitions
-
Malignant epithelial neoplasm (adenocarcinoma) arising from ampulla of Vater
IMAGING
General Features
-
Best diagnostic clue
-
Soft tissue (ST) mass involving ampulla
-
“Double duct” sign with obstruction of both common bile duct (CBD) and pancreatic duct (PD)
-
Lesion best visualized on CECT when duodenum distended with water
-
-
Location
-
Within ampulla of Vater or overlying periampullary duodenal mucosa
-
-
Size
-
1-4 cm in diameter; mean 2.7 cm
-
-
Morphology
-
Often lobulated mass
-
Radiographic Findings
-
ERCP
-
Visible ampullary mass
-
Obstruction of CBD and PD
-
Useful for biopsy
-
Fluoroscopic Findings
-
Upper gastrointestinal: Filling defect in 2nd part of duodenum in region of ampulla of Vater
CT Findings
-
CECT
-
Ampullary mass with variable attenuation (most often hypodense) distinct from pancreas, with dilated CBD and PD
-
Nodal or liver metastases in advanced cases
-
-
MR Findings
-
T1WI
-
Hypointense to pancreas on non-fat-suppressed T1WI
-
-
T1WI FS
-
Isointense or slightly hypointense to pancreas on fat-suppressed T1WI
-
-
T2WI
-
Intermediate signal ampullary mass
-
Dilated main PD and CBD
-
-
T1WI C+
-
Enhancing ST mass of lower signal than pancreas
-
-
MRCP
-
Dilated PD and CBD
-
Up to 76% accuracy
-
Ultrasonographic Findings
-
Grayscale ultrasound
-
Dilated CBD and PD
-
Ampullary mass usually not visible
-
Liver metastases in advanced cases
-
-
Color Doppler
-
No flow in dilated hypoechoic CBD and PD
-
-
Endoscopic US
-
Useful for staging (most accurate modality for T staging) and biopsy
-
Detection of nodal metastases
-
Angiographic Findings
-
Conventional
-
Superselective injection of gastroduodenal artery demonstrates hypovascular mass
-
Nuclear Medicine Findings
-
PET
-
May demonstrate liver metastases as FDG-avid lesions
-
-
Hepatobiliary scintigraphy
-
Dilated bile ducts
-
Imaging Recommendations
-
Best imaging tool
-
CECT with dedicated biphasic pancreatic protocol or multiphasic MR with MRCP
-
-
Protocol advice
-
Patient to drink 16 oz of water just prior to CT
-
Arterial phase acquisition: Rapid bolus injection of 150 mL IV contrast (4-5 mL/s); 1.25 mm collimation after 10-second delay
-
Venous phase acquisition at 70 seconds; 5 mm collimation
-
Reconstruct pancreas images: 20 cm field of view
-
Additional reformations including curved planar reformat of PD and CBD useful
-
DIFFERENTIAL DIAGNOSIS
Pancreatic Head Carcinoma Invading Ampulla
-
Hypoattenuating mass on late arterial-phase CECT
-
Obstructed CBD and PD
Adenoma of Ampulla
-
Indistinguishable from carcinoma on CT
Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

